Clinical Trial Update: A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA

View source ↗

Summary

A completed clinical trial that surveys participants and physicians about knowledge, attitudes, and behavior when using NATPARA for hypoparathyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• NATPARA (parathyroid hormone (rhPTH 1-84))

Snippet

Sponsor: Shire | Conditions: Hypoparathyroidism | Status: COMPLETED